Oulu, Finland

Jing Zhou

This inventor holds 1 USPTO granted patent. Top assignee: Biostratum, Inc.. Active years: 2003.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Jing Zhou: Innovator in Genetic Research

Introduction

Jing Zhou is a notable inventor based in Oulu, Finland. He has made significant contributions to the field of genetic research, particularly in the study of human type IV collagen. His work has implications for understanding various genetic conditions and advancing medical science.

Latest Patents

Jing Zhou holds a patent titled "Method for determining the nucleotide sequence of the gene for the α5(IV) chain of human type IV collagen." This invention relates to a method for isolating and identifying the nucleotide sequence of the human gene for the type IV collagen α5(IV) chain. The patent outlines techniques for determining the nucleotide sequence of the gene, utilizing methods such as cloning from genomic DNA libraries or amplifying gene regions with the polymerase chain reaction (PCR). The invention also emphasizes the use of the nucleotide sequences of the α5(IV) gene for amplification or identification purposes.

Career Highlights

Jing Zhou is associated with Biostratum, Inc., where he continues to engage in innovative research. His work has contributed to advancements in genetic sequencing and understanding the complexities of human collagen.

Collaborations

Jing Zhou has collaborated with notable colleagues, including Sirkka L Hostikka and Karl Kristian Tryggvason. These partnerships have fostered a collaborative environment that enhances research outcomes and innovation.

Conclusion

Jing Zhou's contributions to genetic research, particularly through his patent on the α5(IV) chain of human type IV collagen, highlight his role as an innovator in the field. His work continues to influence advancements in medical science and genetic understanding.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…